Qualitative and quantitative demonstration of bead-to-bead transfer with bone marrow-derived human mesenchymal stem cells on microcarriers: utilising the phenomenon to improve culture performance 
Introduction
Advanced therapies, including cell and gene-based therapies, will form the next generation of therapeutics which have the potential to address unmet clinical need, treat chronic conditions and offer potential cures rather than simply alleviating patient symptoms (Barry and Murphy 2013) .
Adherent, or anchorage-dependent cells, are likely to be promising candidates for both autologous (patient-specific) and allogeneic (universal donor) cell-based therapies; such cells include human adult mesenchymal stem cells (hMSCs), human embryonic stem cells (hESCs) and human induced pluripotent stem cells (hiPSCs). However, the growth of adherent cells presents additional challenges in comparison to suspension cell platforms, and has therefore been the subject of considerable research activity (Rafiq 2016) . Initially in the 1980s and 1990s, significant effort was directed at the production of adherent Chinese Hamster Ovary (CHO) cells for protein/vaccine production, and more recently, for the production of adherent stem cells for cell therapy applications. Established techniques for the growth of these cells involve monolayer culture, predominantly in tissue-culture flasks or roller bottles. However, as was recognised for adherent CHO cells in the 1980s, alternative manufacturing processes for the production of adherent cells are required which are scalable, robust, reproducible and cost-effective. This is achieved through the use of microcarriers in stirred-tank bioreactor systems and have been used for multiple cell types including CHO (Ohlson et al. 1994) , hMSCs (Dos Santos et al. 2011; Rafiq et al. 2013a) , hESCs and hiPSCs (Badenes et al. 2017; Bardy et al. 2013 ).
In monolayer culture, cell growth is maintained by keeping the cells in the log phase of the culture and is based upon 'confluency', the proportion of adherent cells covering the attachment surface.
When cells reach an appropriate confluency level (usually 80% but can differ based on cell type), the cells are removed from the surface and plated into new tissue culture flasks in order to keep typically requires the use of a proteolytic enzyme such as trypsin, dispase or collagenase (Lindner et al. 1987) in conjunction with a chelating agent such as EDTA. The exposure of adherent cells to these reagents in the absence of serum-containing medium enables the digestion and cleaving of cell attachment proteins. However, frequent exposure to such reagents has been demonstrated to have adverse effects on mammalian cells including proteome alteration (Huang et al. 2010 ) and effects on cell shape and chromatin structure (Kapiszewska et al. 1991) . As such there is concern regarding the consecutive passaging of cells, in part due to the long-term deleterious effects of dissociation reagents on the cell cytoskeleton (Madeira et al. 2012) . Although enzyme-free dissociation buffers also exist, some formulations may not be suitable for use with hMSCs. For example, a study using a Gibco-brand enzyme-free dissociation buffer to detach hMSCs grown on tissue culture plastic found that not only was cell viability following detachment significantly reduced compared to trypsin controls (~ 70% compared to > 90%, respectively) but cells also failed to reattach to tissue culture plastic (Heng et al. 2009 ).
Until now, hMSC microcarrier culture has followed the same approach as monolayer culture with respect to harvesting when cells reach confluency, i.e. the use of enzymes to detach cells from the surface of the microcarriers, preferably aided by agitation to reduce the time the cells are exposed to that environment (Nienow et al. 2014) . However, unlike monolayer culture which is limited by the surface area available in the tissue culture flask, microcarrier/bioreactor culture has a significant advantage with respect to surface area to volume ratio and there is potential for the provision of additional microcarriers during a culture process when the cells are nearing confluency in order to maintain cell growth in the exponential phase for longer. For example, Hervy and colleagues recently maintained hMSCs on microcarriers for over 40 days using this (Hervy et al. 2014) . This extended culture time relies on the transfer of cells from one microcarrier/bead to another (called here for convenience, bead-to-bead transfer). Bead-to-bead transfer (or cell migration from one microcarrier to another) during suspension culture of adherent cells is believed to be a key mechanism for rapid and efficient cell expansion in suspension cultures (de Soure et al. 2016) . This cell behaviour is of particular interest from a process development and manufacturing perspective as the demonstration of bead-to-bead transfer would facilitate the large-scale manufacture of stem cells via seed bioreactor cultures without the need to expose the cells to frequent deleterious proteolytic enzymes. This approach also facilitates process intensification by providing additional surface throughout the course of the culture, maintaining the cells in the exponential phase of growth for a longer period of time, thereby increasing yield and efficiency whilst reducing process costs and time.
Although investigated and proven for adherent CHO and Vero cells (Ohlson et al. 1994; Wang and Ouyang 1999) , work demonstrating such a phenomenon for hMSCs has to date focused on single hMSC donors (Takahashi et al. 2017) , or an immortalised cell line (hMSC-TERT) (Leber et al. 2017) or it included complex agitation regimes (Hervy et al. 2014) . In this study, we demonstrate, both qualitatively and quantitatively, the phenomenon of bead-to-bead transfer for three donor BM-hMSCs on different microcarriers (Plastic P102-L, Cytodex-3 and Hillex) in different culture medium conditions, foetal bovine serum (FBS), human platelet lysate (HPL) and serum-free medium (SFM). We also explore the use of a cells-on-beads inoculation procedure, which subsequently utilises bead-to-bead transfer (henceforth called 'cells-on-beads inoculation'), in contrast to the standard free suspension inoculation procedure to facilitate process intensification. Several important parameters were measured throughout the culture including cell 
Materials and methods

hMSC monolayer expansion
Human MSCs from three donors were used in this study. All were isolated from bone-marrow aspirate and obtained from Lonza (Walkersville, USA) after the donors provided informed consent. The university's local Ethical Committee approved the use of the samples for research.
The isolation and culture of primary hMSCs is described in Rafiq et al. (2013b) ; in brief, hMSCs were isolated on the basis of plastic adherence and cryopreserved at passage 1 at a density of 2 x 10 6 cells/mL in 10 % dimethyl sulphoxide (DMSO) (v/v) (Sigma Aldrich, UK) and 90 % foetal bovine serum (FBS; Hyclone, Lot# RUF35869). The cells were cultured according to previously determined protocols (Rafiq et al., 2013; Heathman et. al., 2015) . Briefly, the cells were seeded at 5,000 cells/cm 2 and grown on tissue culture plastic in DMEM (1 g/L glucose, Lonza, UK) supplemented with 10% (v/v) foetal bovine serum (FBS; HyClone) or 10% (v/v) non-heparin requiring (PL-NH) Stemulate™ (Cook Regentec, USA) for the human platelet lysate based culture conditions, and 2 mM UltraGlutamine (Lonza, UK).
Where cells were also cultured under serum-free medium (SFM) conditions, the Prime-XV TM SFM hMSC medium was used (Irvine Scientific, USA) in accordance with the manufacturer's instructions. As required, attachment surfaces were pre-coated with recombinant fibronectin (Irvine Scientific, USA). For both the SFM and HPL cultures, the BM-hMSCs underwent one adaptation passage in medium containing either the Prime-XV TM medium or 10% (v/v) PL-NH Stemulate™.
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Spinner flask microcarrier culture
The spinner flask cultures involved the use of 100 mL BellCo spinner flasks (BellCo, USA), with a 100 mL working volume and a vessel diameter (T) of 60 mm. The spinner flask vessels were siliconized prior to use with Sigmacote (Sigma Aldrich, UK) as described in ).
The spinner flasks were agitated by a magnetic stirrer bar at the just suspended speed (NJS) placed on the Bell-Ennium TM Compact 5 position magnetic stirrer platform (BellCo, USA) with air in the headspace for surface aeration giving essentially 100% dO2. The microcarriers were prepared according to the manufacturer's instructions and sterilised by autoclaving at 121ºC and 1 atm for 15 minutes. Prior to use, the microcarriers were conditioned in growth medium for at least 1 hour to facilitate cell attachment. The surface area provided per spinner flask was 500 cm 2 and the cells were inoculated at a density of 6,000 cells/cm 2 as previously described (Rafiq et. al., 2013; Heathman et. al., 2015) . This inoculation method, referred to later as the 'control', is in contrast to the 'cells-on-beads' inoculation method (discussed later in the results section) which involved inoculating 10% of near-confluent microcarriers from an initial seed microcarrier culture.
In all cases, a 50% medium exchange was performed at 72 h in culture and then every 48 h thereafter.
Analytical Techniques
Cell counts and viability (via acridine orange uptake and DAPI exclusion) were determined using the Nucleocounter NC-3000 (Chemometec, UK). Cell viability was also assessed by the Live/Dead Viability/Cytotoxicity kit (Calcein AM/ Ethidium Homodimer; Life Sciences, ThermoFisher, UK) following the manufacturer's instructions. Briefly, the cells were first washed with PBS and then incubated with the Live/Dead stain containing a final concentration of 2 µM Field Code Changed calcein-AM and 4 µM ethidium homodimer in the dark at 37ºC and 5% CO2 for 40 minutes. Post incubation, the Live/Dead working solution was removed and replaced with PBS. Samples were then visualised on a Nikon Ti Eclipse epi-fluorescence microscope (Nikon, UK).
Analysis of glucose and lactate concentrations in the spent medium was performed using a Cedex Bio-HT (Roche, Germany). The following parameters were calculated from the data obtained:
where µ is the net specific growth rate (h -1 ), Cx(t) and Cx(0) are the cell numbers at the end and start of the exponential growth phase, respectively and t is time (h).
Population Doublings
where Pd is the number of population doublings, Cx(t) and Cx(0) are the cell numbers at the end and start of the exponential growth phase, respectively.
Specific Metabolite Consumption/Production Rate
where qmet is the net specific metabolite consumption or production rate, µ is the specific growth rate (h -1 ), Cx(0) is the cell number at the end of the exponential growth phase, Cmet(t) and Cmet (0) are the metabolite concentrations at the end and start of the exponential growth phase, respectively and t is time (h).
hMSC Characterisation
Immunophenotype analysis was performed by multiparameter flow cytometry before and after the hMSC expansion process using a previously developed protocol (Chan et al. 2014) . In brief, this used for this study. The labelled cells were allowed to attach and proliferate for 48 h in agitated conditions, in the dark, at 37ºC and 5% CO2. After 48 h in culture, the different microcarrierlabelled cell suspensions were mixed in a 50:50 proportion and the culture was continued for an additional 2 days. The mixed microcarrier-labelled cell suspensions were then imaged on the epifluorescence microscope mentioned above.
Statistical analysis
For comparison between the two data sets comparing the mean specific growth rates, statistical significance was determined by using the Student's two-tailed t-test. Significance was determined Formatted: Font color: Auto at p < 0.05 (*) or p < 0.01 (**). GraphPad Prism 6 (California, USA) was used for the statistical analysis
Results and Discussion
The aim of this work was to demonstrate, both quantitatively and qualitatively, the phenomenon of bead-to-bead transfer of hMSCs on microcarriers under different culture conditions including cells from three BM-hMSC donors and under different culture medium conditions, FBS, HPL and SFM.
An additional aim was to investigate the potential for process intensification through cells-onbeads inoculation, where 10% of near-confluent microcarriers were used to inoculate a fresh microcarrier culture.
Cell-microcarrier contact in bead-to-bead hMSC transfer is very likely to be influenced by a combination of factors such as donor cell line, medium composition, attachment substrate (i.e. microcarriers) and the process itself. The process employed with respect to the feeding regime, surface area provided or agitation intensity was kept constant during this study using a protocol that had been thoroughly tested and optimised for the successful expansion of bone-marrow derived hMSCs in spinner flasks in different medium conditions (Heathman et al. 2015; Rafiq et al. 2016) . To account for donor variability, hMSCs from three donors were employed for this study.
Qualitative demonstration of bead-to-bead transfer
To qualitatively demonstrate hMSC migration from one microcarrier to another, two different methods were employed. The first method made use of commercially available microcarriers with different visual properties, while the second method consisted of fluorescently-labelling cells, followed by tracking their movements in culture.
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Prior work with multiple types of microcarriers in a microcarrier screening study showed that BM-hMSCs would attach and grow on most of the microcarriers albeit with varying degrees of success on each. It was also found that certain microcarriers were visually distinctive compared to others, for example the Cytodex-1 microcarriers are translucent in comparison to the solid Plastic P102-L microcarriers, and the Hillex microcarriers absorb the phenol red present in the medium and therefore turn a dark red colour. To demonstrate the phenomenon of hMSC bead-to-bead transfer qualitatively, the BM-hMSCs were initially cultured exclusively on Plastic P102-L microcarriers for a period of 6 days, after which fresh Hillex microcarriers ( Figure 1A -C) or fresh Cytodex-1 microcarriers ( Figure 1D -F) were aseptically added to the culture without stopping agitation of the culture at any point.
As is indicated by the arrows in the figures, it is evident that BM-MSCs were attached to both the Plastic P102-L microcarriers (solid white) and the Hillex (dark red) microcarriers ( Figure 1A-C) .
Similarly, cells were attached to the Plastic P102-L and Cytodex 1 (translucent white) microcarriers ( Figure 1D-F) . The BM-hMSCs were found to be growing on microcarriers of both types as either cell-microcarriers aggregates, as well as on individual Plastic P102-L, Hillex and Cytodex-1 microcarriers ( Figure 1A-F) . This observation is consistent with both the bridging and cell migration methods of bead-to-bead transfer noted by Leber and colleagues in their studies using an immortalised hMSC line (Leber et al. 2017) . It is worth noting that following the addition of the second type of microcarrier to the culture vessel, at no point was the agitation stopped and NJS was maintained throughout. These findings therefore provide a qualitative demonstration of bead-to-bead transfer during a continuing culture, whereby hMSCs have attached and proliferated on 'fresh' microcarriers days after the addition to the culture.
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Quantitative demonstration of bead-to-bead transfer
To quantitatively demonstrate bead-to-bead transfer, BM-hMSC1 and BM-hMSC2 were grown for With each consecutive culture, it is noteworthy that the initial lag phase is reduced and with each culture, the final cell density obtained by the end is greater than the previous. For FBS cultures, the final cell density was found to be ~1.6 x 10 5 ± 0.15 cells/mL obtained with Culture 1, 2.01 x 10 5 ± 0.06 cells/mL in Culture 2 and ~2.15 x 10 5 ± 0.08 cells/mL obtained in Culture 3 for hBM-MSC1 and a similar trend was found for hBM-MSC2 (Figure 4 ). For SFM cultures, the cell yield was higher in all cases, but the same trend of reduced lag phase and increasing yield within the same time period (6 days) was noted. Moreover, in all cases, viability was > 95%, indicating favourable culture conditions in the vessel for the growth of hMSCs throughout the course of each culture. These findings indicate that a 10% concentration of near-to-confluent microcarriers was not only sufficient to inoculate a new vessel containing 90% fresh microcarriers, but decreased the lag phase of the new culture and increased the overall yield.
The findings would appear to demonstrate bead-to-bead transfer given the fact that a 10% microcarrier concentration (with cells attached) was able to successfully inoculate a culture vessel with fresh microcarriers, with the culture eventually reaching a point of near-confluency prior to termination of the culture. Similar findings were observed by Ohlson et al. (1994) and Wang and Ouyang (1999) for adherent CHO cells who performed similar inoculation studies with nearconfluent and fresh microcarriers. Moreover, Ohlson et al. (1994) also observed an increase in the overall cell yield and a reduced lag phase, similar to what was found in this study. In addition to investigating a 10% addition of near-confluent microcarriers to a culture containing fresh microcarriers, Ohlson et al. (1994) also investigated inoculating a 25% concentration of nearconfluent microcarriers to a fresh culture and found that this resulted in a further reduced lag phase and an even greater cell density than the 10% near-confluent microcarrier addition.
Although a 25% concentration of near-confluent microcarriers were not investigated in our study, that earlier finding indicates that an important process development activity might be to establish the optimal concentration of near-confluent microcarriers to inoculate into fresh bioreactor systems. This analysis will undoubtedly be a trade-off between the number of bioreactors to be seeded and the desired culture growth kinetics (similar to splitting a near-confluent T-flasks into multiple T-flasks). In a separate study, Badenes et al. (2017) demonstrated bead-to-bead transfer with hIPSCs, where it was found that this technique facilitated an increase in viable cell number and a concomitant significant increase in fold expansion within a 15 day culture.
To further quantitatively demonstrate the phenomenon of bead-to-bead transfer, a fluorescence microscopy-based manual cell counting technique was adopted to highlight the difference between two inoculation methods. One 
Comparison of inoculation techniques
Having established that BM-hMSCs can transfer to freshly added microcarriers and that a 10%
concentration of near-confluent microcarriers could act as a sufficient inoculum for a fresh culture, to further prove the efficacy of the new approach, it was decided to include cells from a third The results are also compared to our previous approach of free suspension inoculation as control ; Heathman et al. (2015) ). Though the results differed between the different medium, the data were very similar for each donor cell. Thus, the data presented in Figures 6-9 illustrate a typical result for any of the cells in that specific medium conditions.
There was a significant improvement in performance between the two approaches in all culture medium conditions (FBS, HPL and SFM) throughout the course of the culture, resulting in a higher cell density at the end of the culture when utilising cells-on-beads inoculation. For the FBSbased culture, the cell density was ~ 2.0 x 10 5 cells/mL compared to ~1.5 x 10 5 cells/mL respectively ( Figure 6A ) and for SFM, the final cell densities were ~4.6 x 10 5 cells/mL, compared to ~3.4 x 10 5 cells/mL respectively ( Figure 7A ). A similar trend was found for HPL, where the values were ~3.6 x 10 5 and ~3.0 x 10 5 cells/mL respectively ( Figure 8A ). This increase in cell yield is associated with a reduced lag phase for all cultures using the cells-on-beads inoculation method, enabling the cells to reach the higher growth phase of the culture quicker in comparison to the control. This more rapid achievement of fast growth is illustrated in Figures 6-8B and Figures 6-8C. Figures 6-8 B, shows that for FBS, SFM and HPL cultures, the cells' mean specific growth rate was significantly higher between days 0-2 with the cells-on-beads inoculation when compared to the controls (Figures 6-8C ). After that, the growth rate for each method reached parity between days 2-4. These figures also make clear that there was a reduced lag phase with cells-on-beads inoculation.
The specific glucose consumption rate along with the specific lactate and ammonia production rates were also calculated for each culture (Figure 9 ). For FBS-based culture, the specific glucose consumption rate during pre-culture for both the inoculation via cells-on-beads and the control method was ~19 pmol.cell -1 .d -1 . Then between days 0-2 post inoculation, these values sharply rose to ~38 pmol.cell -1 .d -1 for the inoculation via cells-on-beads and was even higher (~45 pmol.cell -1 .d -1 ) for the control. Between days 2-4, the glucose consumption rates have settled back down to similar values of ~20 pmol.cell -1 .d -1 for both methods. This increase in specific glucose consumption rate during the first 2 days of culture was mirrored by an increase in the specific lactate and ammonia production rates during the same time phase. A distinct trend could be seen across each medium type, where in general an increase in specific consumption/production rates over the first 2 days of culture was significantly reduced when using the inoculation via cells-on-beads instead of the control. It must be noted that all rates were significantly reduced when using a serum-free medium.
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This trend suggested that using inoculation by cells-on-beads resulted in a reduced impact on the metabolic activity of the hMSCs during the early phase of culture that can likely be attributed to the production of extracellular components required for attachment when using the control method. Although it has not been explored here, this highlights a potential impact of multiple trypsinisation steps on the potency or long-term proliferative capability of hMSCs which could be avoided by adopting the inoculation via cells on beads followed by bead to bead transfer.
With respect to characterisation, the BM-hMSCs, both pre-inoculation and post-harvest were characterised with respect to cell identity (immunophenotypic expression) and functionality (differentiation potential). In all cases (different culture medium conditions and inoculation methods), the BM-hMSCs were found to be in accordance with the ISCT criteria (Dominici et al. 2006) . Representative data is shown for the condition wherein the BM-hMSCs were cultured in SFM and inoculated using cells-on-beads. However similar findings were found for all other conditions (data not shown). The data demonstrates that there was > 95% co-expression of CD105, CD90 and CD73 and less than 2% positive for the negative markers CD34 and HLA-DR for the harvested BM-hMSCs (Supplementary Figure 1) . Moreover, the cells were analysed for the retention of their tri-lineage differentiation potential towards the osteogenic, chondrogenic and adipogenic pathways. Again, in all cases, the BM-hMSCs were found to retain their differentiation potential (Supplementary Figure 1) .
The impact of this study is particularly relevant to the production phase for hMSC manufacture, where the need for large numbers of cells within a limited time period may be necessary. This approach allows for multiple bioreactors to be inoculated and operated in parallel from a small percentage of near-confluent microcarriers, which lends itself well to an allogeneic cell therapy. 
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Conclusions
Bead-to-bead transfer is widely believed to occur in anchorage-dependent microcarrier cultures.
Unlike previous studies investigating this phenomenon, this study describes the approach taken to demonstrate bead-to-bead transfer, both qualitatively and quantitatively, for three different BM- Data show mean ± SD, n = 3. Significance was determined at p < 0.05 (*) or at p < 0.01 (**). (A-C) represents the mean specific glucose consumption rate (pmol.cell -1 .d -1 ), the mean specific 
